Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Sale-Or-Purchase-of-Stock" stands at -101.58 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 12/31/2022.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -99.70 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -99.70 Billion Japanese Yens.
The 3 year change is 0.337 Billion Japanese Yens.
The 5 year change is -99.43 Billion Japanese Yens.
The 10 year change is -79.24 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Sale Or Purchase of Stock | 905,699,262,464.00 |
![]() | Johnson & Johnson - Sale Or Purchase of Stock | 486,508,953,600.00 |
![]() | AbbVie Inc - Sale Or Purchase of Stock | 399,570,305,024.00 |
![]() | Roche Holding AG - Sale Or Purchase of Stock | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Sale Or Purchase of Stock | 280,205,508,085.11 |